NX Pharmagen

United States
Sycamore, Georgia, United States, 40207

Company profile

NX Pharmagen company profile

NX PharmaGen’s business model is to acquire, develop, and monetize mature clinical-stage breakthrough technologies. The company’s lead program is a disruptive diagnostic technology, termed the NeXosomeTM Platform, which is designed to yield.

Business identity

Contact email
[email protected]
Phone number
+1 8887887249
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2010-01-01, Year

Headquarters

Postal code
40207
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
5
Total equity funding
$5.8M
Last funding
Debt Financing / $590,000 / 2022-10-21
Last equity funding
Series Unknown / $486,000
Investors
1
Founders
1
Articles
5

Founders and investors

Founders

Alan Ezrin

Investors

Keyhorse Capital